Brief: Eagle Pharmaceuticals Announced Resumption Of Repurchases Of Common Stock On Open Market
18/07/2023 13:44
July 18 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS INC SAYS ON JULY 18, CO ANNOUNCED
THAT IT
HAD RESUMED REPURCHASES OF COMMON STOCK ON OPEN MARKET - SEC
FILING
* EAGLE PHARMACEUTICALS INC SAYS UNDER EXISTING SHARE
REPURCHASE
PROGRAM, CO MAY REPURCHASE COMMON STOCK FOR UP TO $160 MILLION
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq